The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

By Karagiannis Asterios   Mikhailidis Dimitri P   Athyros Vasilios G   Kakafika Anna I   Tziomalos Konstantinos   Liberopoulos Evangelos N   Florentin Matilda   Elisaf Moses  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 191-205

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor blockers for the treatment of hypertension

By See Sharon  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1795-1804

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade

By Parvanova Aneliya   Chiurchiu Carlos   Ruggenenti Piero   Remuzzi Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1931-1942

Informa Healthcare

Access to resources Recommend Favorite

The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension

By Thomas G. Neil  

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 131-155

Adis International

Access to resources Recommend Favorite

ACE inhibitors and angiotensin receptor blockers (ARBs) appear to be beneficial in patients with acute renal transplant failure

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite